In this episode of Breast Cancer Breakthroughs, we speak with Komen grantees Dr. Tarah Ballinger, medical oncologist at Indiana University School of Medicine, and Dr. Pedram Razavi, medical oncologist at Memorial Sloan Kettering Cancer Center, about the biggest highlights from the 2024 ASCO Annual Meeting and what they could mean for patients.| Susan G. Komen®
Takeaways from ECOG-ACRIN trial results presented at the 2024 American Society of Clinical Oncology Annual Meeting| ECOG-ACRIN Advocacy Blog